Skip to Content
Merck
  • Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management.

Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management.

Brain & development (2017-01-25)
Mahmoud Reza Ashrafi, Ali Reza Tavasoli
ABSTRACT

Childhood leukodystrophies are a growing category of neurological disorders in pediatric neurology practice. With the help of new advanced genetic studies such as whole exome sequencing (WES) and whole genome sequencing (WGS), the list of childhood heritable white matter disorders has been increased to more than one hundred disorders. During the last three decades, the basic concepts and definitions, classification, diagnostic approach and medical management of these disorders much have changed. Pattern recognition based on brain magnetic resonance imaging (MRI), has played an important role in this process. We reviewed the last Global Leukodystrophy Initiative (GLIA) expert opinions in definition, new classification, diagnostic approach and medical management including emerging treatments for pediatric leukodystrophies.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glycerol trienanthate, ≥94%
Sigma-Aldrich
Orotic acid, ≥98% (titration), anhydrous